SPWG
ABBV icon

Syntegra Private Wealth Group’s AbbVie ABBV Stock Holding History

Syntegra Private Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Sell
14,062
-47
-0.3% -$10.1K 0.27% 33
2026
Q1 		$3.07M Sell
14,109
-119
-0.8% -$26.4K 0.29% 36
2025
Q4 		$3.25M Sell
14,228
-758
-5% -$173K 0.3% 36
2025
Q3 		$3.47M Buy
14,986
+195
+1% +$39.7K 0.33% 35
2025
Q2 		$2.75M Sell
14,791
-47
-0.3% -$8.73K 0.28% 34
2025
Q1 		$3.11M Buy
14,838
+2
+0% +$389 0.36% 28
2024
Q4 		$2.64M Buy
14,836
+462
+3% +$84.9K 0.3% 29
2024
Q3 		$2.84M Buy
14,374
+8
+0.1% +$1.49K 0.33% 28
2024
Q2 		$2.46M Buy
14,366
+128
+0.9% +$21.2K 0.31% 28
2024
Q1 		$2.59M Buy
14,238
+297
+2% +$51.2K 0.33% 27
2023
Q4 		$2.16M Buy
13,941
+455
+3% +$66.3K 0.3% 28
2023
Q3 		$2.01M Buy
13,486
+24
+0.2% +$3.52K 0.32% 29
2023
Q2 		$1.81M Buy
13,462
+100
+0.7% +$14.7K 0.28% 33
2023
Q1 		$2.13M Buy
13,362
+29
+0.2% +$4.43K 0.38% 28
2022
Q4 		$2.15M Buy
+13,333
New +$2.04M 0.43% 26

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Syntegra Private Wealth Group's ABBV Position: Q2 2026 in Review

Syntegra Private Wealth Group reduced its AbbVie (ABBV) stake by 0.33% in Q2 2026, selling an estimated $10.1K and leaving 14,062 shares worth $3.54M. The position accounts for 0.27% of the portfolio, ranked #33.

Syntegra Private Wealth Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Syntegra Private Wealth Group held 14,062 shares of AbbVie worth $3.54M as of Q2 2026.
  • Syntegra Private Wealth Group sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
  • AbbVie made up 0.27% of Syntegra Private Wealth Group's portfolio in Q2 2026, its #33 holding.
  • Syntegra Private Wealth Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Syntegra Private Wealth Group's 13F filing for Q2 2026, filed 15 Jul 2026.